Mr. Kingsley has nearly three decades of biotechnology, pharmaceutical and medical device industry experience. Prior to joining TARIS, he served as president and chief operating officer at The Medicines Company. Previously, Mr. Kingsley was global commercial head at Biogen, where he drove the global launches of products Tecfidera® and PLEGRIDY ® for multiple sclerosis, launched Biogen’s entry into the hemophilia business, and founded Biogen’s commercial biosimilars business in Europe. Prior to Biogen, he was senior vice president and general manager of the gynecological surgical products business at Hologic, Inc., and was division president, diagnostic products at Cytyc Corp. Mr. Kingsley was a partner at McKinsey & Company, focused on the biotechnology, pharmaceutical and medical device industries. He is a member of the board of directors of Proteon Therapeutics, Inc. Mr. Kingsley received a B.A. in government from Dartmouth College and an M.B.A. from Harvard Business School.